MUSLF (Promino Nutritional Sciences) EBITDA Margin %: -216.24% (As of Mar. 2026)


What is Promino Nutritional Sciences EBITDA Margin %?

Promino Nutritional Sciences MUSLF -13.58% EBITDA Margin % is -216.24% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 1,951 Consumer Packaged Goods companies, Promino Nutritional Sciences ranks worse than 97.49% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Promino Nutritional Sciences's EBITDA for the three months ended in Mar. 2026 was $-0.25 Mil. Promino Nutritional Sciences's Revenue for the three months ended in Mar. 2026 was $0.12 Mil. Therefore, Promino Nutritional Sciences's EBITDA margin for the quarter that ended in Mar. 2026 was -216.24%.


Promino Nutritional Sciences  (OTCPK:MUSLF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Promino Nutritional Sciences EBITDA Margin % Related Terms


Promino Nutritional Sciences EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Promino Nutritional Sciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Promino Nutritional Sciences EBITDA Margin % Chart

Promino Nutritional Sciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial -367.95 -254.34 -1,103.93 -2,631.69 -124.86

Promino Nutritional Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -179.67 -240.48 28.78 -226.80 -216.24

MUSLF vs KHC, GIS: EBITDA Margin % Comparison

For the Packaged Foods subindustry, Promino Nutritional Sciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Promino Nutritional Sciences EBITDA Margin % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Promino Nutritional Sciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Promino Nutritional Sciences's EBITDA Margin % falls into.



Promino Nutritional Sciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Promino Nutritional Sciences's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.949/1.561
=-124.86 %

Promino Nutritional Sciences's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.253/0.117
=-216.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -216.24% mean?
Promino Nutritional Sciences (MUSLF) has a EBITDA Margin % of -216.24% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Promino Nutritional Sciences and its competitors. According to the industry distribution chart, Promino Nutritional Sciences ranks #1902 out of 1951 companies in the Consumer Packaged Goods industry, placing it in the top 97.5%.
Is Promino Nutritional Sciences' EBITDA Margin % too high?
Promino Nutritional Sciences' current EBITDA Margin % is -216.24%. Based on the distribution chart, Promino Nutritional Sciences ranks #1902 out of 1951 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does Promino Nutritional Sciences' EBITDA Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Promino Nutritional Sciences ranks #1902 out of 1951 companies for EBITDA Margin %. This places Promino Nutritional Sciences in the lower half of its industry. The industry median EBITDA Margin % is 8.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.97, based on 1,951 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Promino Nutritional Sciences and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promino Nutritional Sciences's current EBITDA Margin % is -216.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promino Nutritional Sciences stock overvalued right now?
Based on GuruFocus' analysis, Promino Nutritional Sciences (MUSLF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.12, compared to a current price of $0.02 — trading 86% below its estimated fair value. The current EBITDA Margin % is -216.24%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Promino Nutritional Sciences (MUSLF), the current EBITDA Margin % is -216.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Promino Nutritional Sciences Business Description

Other Exchanges 93X:GermanyMUSL:Canada
Address 4145 North Service Road, 2nd Floor, Burlington, ON, CAN, L7L 6A3
Promino Nutritional Sciences Inc is a producer, distributor, and vendor of consumer-packaged nutritional products. Promino's product, Rejuvenate, is a patented proprietary formula that assists in the building, rebuilding, restoration, and rejuvenation of natural muscle mass. Promino also offers Promino, a performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength, and accelerate recovery from injury.